TrialThe Journal of clinical investigation2021
A replication-competent adenovirus-vectored influenza vaccine induces durable systemic and mucosal immunity.
Kenta Matsuda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
54 papers cite it
this paperpooled ittrialcites it